Long-term follow-up of the London patient suggests no detectable active HIV virus remains in the patient. THE LANCET Long-term follow-up of the London patient suggests no detectable active HIV virus remains in the patient. Although the treatment is high-risk and only suitable for certain patients, the results provide evidence that this patient is the second...